Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK2 | Q9NRA0 | 6/20 | 0.46 |
| ▸ | SPHK1 | Q9NYA1 | 6/20 | 0.46 |
| ▸ | FUCA1 | P04066 | 2/20 | 0.44 |
| ▸ | GBA1 | P04062 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | GUSB | P08236 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16644838 | 0.98 | SPHK2 (0.43) | SPHK2SPHK1FUCA1GBA1GAA | |
| SCHEMBL21449766 | 0.92 | FUCA1 (0.41) | SPHK2SPHK1FUCA1GBA1 | |
| SCHEMBL16644799 | 0.92 | FUCA1 (0.41) | SPHK2SPHK1FUCA1GBA1 | |
| SCHEMBL23849014 | 0.92 | FUCA1 (0.41) | SPHK2SPHK1FUCA1GBA1 | |
| SCHEMBL21449807 | 0.84 | FUCA1 (0.44) | FUCA1GAA | |
| SCHEMBL12609368 | 0.84 | FUCA1 (0.44) | FUCA1GAA | |
| SCHEMBL21449884 | 0.82 | FUCA1 (0.40) | FUCA1 | |
| SCHEMBL4551711 | 0.82 | SPHK2 (0.47) | SPHK2SPHK1FUCA1GBA1GAA | |
| SCHEMBL12899779 | 0.81 | FUCA1 (0.41) | FUCA1 | |
| SCHEMBL17010813 | 0.81 | ALDH1A1 (0.46) | SPHK2SPHK1FUCA1GBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210214607-A1 | LONG WAVELENGTH EMITTING CHEMILUMINESCENT PROBES | NEMIS TECHNOLOGIES AG (CH) | 2021-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210214607-A1 | LONG WAVELENGTH EMITTING CHEMILUMINESCENT PROBES | VEGFA, GUSB, NR2E3 | SPHK2 4520/4885SPHK1 4107/4885FUCA1 2420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.